# Trade Mark Journal No.2025/050 12 December 2025

## WO0000001888745 (5,35,42,44)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:24 April 2025
Date of designation in the UK: 24 April 2025

International priority date claimed: 25 October 2024 (European Union Intellectual Property Office (EUIPO)) (019096656)

Class 5
  Chemical products for medical diagnosis; diagnostic preparations for medical use, using t-cell receptors (tcrs); diagnostic preparations for medical use; diagnostic radiopharmaceutical preparations; diagnostic reagents for medical or veterinary use in in vitro diagnosis; diagnostic substances for medical use; diagnostic test kits for cancer diagnosis; diagnostic test kits for individual medical diagnosis; diagnostic test kits for tumour identification; diagnostic test kits for use in oncology; diagnostic test reagents for veterinary use; indicators for medical diagnosis; medical diagnostic reagents; medical preparations; pharmaceutical drugs; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances; pharmaceutical preparations for diagnosis; pharmaceutical preparations for diagnostic purposes; pharmaceutical preparations for individual medical diagnosis; pharmaceutical preparations for medical purposes; pharmaceutical preparations for medical test kits for cancer diagnosis; pharmaceutical preparations for medical test kits for individual medical diagnosis; pharmaceutical preparations for medical test kits for use in oncology; pharmaceutical preparations for medical test kits; pharmaceutical preparations for suppressing tumours; pharmaceutical preparations for the diagnosis of diseases; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations; pharmaceutical products, medical and veterinary preparations; pharmaceuticals for the treatment of cancer; pharmaceuticals; preparations for medical diagnosis; reactants for medical diagnosis; reagents and preparations for use in diagnostic tests for medical purposes; reagents for diagnostic tests for medical use; tests and test kits for profiling, in particular genomic and proteomic profiling, for use in the selection of therapeutics; tests and test kits for the diagnosis of diseases; tests, test kits, preparations and reagents using t-cell receptors (tcrs) for oncological purposes; tests, test kits, preparations and reagents using t-cell receptor (tcr) clusters for oncological purposes; tumour suppressing agents; immunomodulators; immunostimulants; immunotherapeutic agents; pharmaceutical products for the treatment of autoimmune diseases and autoimmune disorders, pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of immune system disorders.
Class 35
  Maintenance of databases of medical patient information; maintenance of databases of oncological information; maintenance of medical databases; maintenance of databases.
Class 42
  Blood analysis services; development of databases of medical patient information; development of databases of oncological information; development of databases of sequenced t-cell receptors (tcrs); development of medical databases; development of databases; development of pharmaceutical preparations and medicines; laboratory services in the medical field; maintenance of databases; medical research in the field of immunology, oncology, infectiology and vaccines; performing analyses for medical research; performing chemical analyses; platform as a service; research and development of pharmaceutical preparations for treating malignant tumours; research of pharmaceuticals; research services in the field of medical analyses and diagnostics; scientific research and development in identification of tumour antigens; scientific research and development in the field of immunology, oncology, infectiology and vaccines; scientific research and development in the field of t-cell receptors (tcrs); scientific research and development; software as a service; scientific research and development services for medical and pharmaceutical purposes in relation to the following fields: immunology, oncology, infectiology and vaccines; research and development services in connection with pharmaceutical and medical preparations, medicine and pharmaceuticals in relation to the following fields: immunology, oncology, infectiology and vaccines; computerised medical evaluation and diagnostic services in relation to the following fields: immunology, oncology, infectiology and vaccines.
Class 44
  Computerised medical evaluation and diagnostic services in relation to the following fields: immunology, oncology, infectiology and vaccines; computerised medical diagnostic services in relation to the following fields: immunology, oncology, infectiology and vaccines.

HS Diagnomics GmbH

Representative: SCHULZ JUNGHANS PATENTANWÄLTE PARTGMBB, Großbeerenstraße 71 1. Hof, Remise, rechts, 10963 Berlin, GERMANY